Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you the outcome of meeting of Board of Directors of the Company ....
PFIZER · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Pfizer Limited's Board approved audited FY2026 results showing revenue from operations of Rs 2,519.65 crore, up 10.4% from Rs 2,281.35 crore in FY2025. Net profit declined to Rs 722.43 crore from Rs 767.60 crore mainly due to Rs 49.16 crore in exceptional items (personnel separation costs of Rs 41.73 crore from the Cipla distribution partnership and Rs 7.43 crore for new labour codes provision). The Board recommended a final dividend of Rs 75 per share (750%) totaling Rs 343.11 crore, payable after August 4, 2026 to shareholders on record July 17, 2026. The statutory auditors B S R & Co. LLP issued an unmodified (clean) opinion. The 75th AGM will be held on July 28, 2026 via video conferencing. The company appointed M/s. Kishore Bhatia & Associates as Cost Auditors for FY2027.
The company delivered revenue growth with strong cash generation, though profit was impacted by one-time restructuring charges. The 750% dividend payout signals confidence and provides income to shareholders. The clean audit opinion and healthy cash reserves (Rs 3.1 billion in bank balances) are positive indicators for investors.